B.01_Combined_Synopsis_and_Solicitation_W81K00-19-T-M022_Attachment_1_Required_Immunochemistry_Stains_Matrix.xlsx

XLSX spreadsheet 20 KB Posted

Attached to
Immunochemistry Stains
Solicitation number
W81K00-19-T-M022
Issued by

About this file

Attachment 1 - Required Stains

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

FY19 - Base Period

Immunochemistry Stains FY19
1 Sep to 30 to Sep 2019
CPTDescriptionEstimated QuantityUnit Price per ResultExtended Price
81210MOLECULAR BRAF, GENE ANALYSIS2$ - 020121.67
81235MOLEC EGFR GENE ANALYSIS, COMMON VARIANTS2$ - 0201.67
81275KRAS GENE ANALYSIS1$ - 0151.25
81276KRAS EXON 3 VARIANTS1$ - 0151.25
81301MICROSATELLITE INSTABILITY ANALYSIS2$ - 0201.67
81305MYD88 GENE ANALYSIS1$ - 050.42
81311NRAS EXON 2, 3 VARIANTS1$ - 050.42
81403JAK2; LEVEL 4 DNA SEQUENCE ANALYSIS1$ - 050.42
81404PIK3CA1$ - 050.42
88237TISS CULT FOR NEOPLST DISORDERS, BN MRW, BLD CELL1$ - 0100.83
88239TISSUE CULTURE FOR CHROMOSOME-SOLID TUMOR1$ - 0100.83
88261CHRM ANALYSIS,CT 5 CELL, 1 KAROTYPE WITH BANDING1$ - 0100.83
88262CHROMOSOME ANALYSIS, 15-20 CELLS1$ - 0100.83
88263CHROMOSOME ANALYSIS, COUNT 45 CELLS FOR MOSAICISM1$ - 050.42
88264CHROMOSOME ANALYSIS, 20-25 CELLS1$ - 0100.83
88267CHRM ANALYSIS,AMNIO FLD OR CHORIONIC VILLUS CNT 15 CL1$ - 0100.83
88271MOLECULAR CYTOGENETICS PROBE2$ - 0201.67
88280CHRM ANALYSIS; ADDITIONAL KAROTYPES, EACH STUDY2$ - 0201.67
88291INTERPRETATION AND REPORT17$ - 020016.67
88305GROSS & MICRO, LEVEL 41$ - 0151.25
88313SPECIAL STAIN, ROUTINE4$ - 0453.75
88321PATHOLOGY SLIDE CONSULT3$ - 0302.50
88323PATHOLOGY CONSULTATION WITH PROCESSING4$ - 0453.75
88341IMMUNOHISTOCHEMISTRY,EACH ADDITIONAL ANTIBODY23$ - 027522.92
88341TCTECH ‐ IMMUNOHISTOCHEMISTRY,EACH ADDTL ANITBODY1$ - 010.08
88342IMMUNOHISTOCHEMISTRY, 1ST ANTIBODY8$ - 01008.33
88342TCTECH ‐ IMMUNOHISTOCHEMISTRY, 1ST ANTIBODY1$ - 010.08
88346IMMUNOFLUORESCENT STUDY, EA SPECIMEN 1ST ANTIBODY1$ - 0151.25
88348ELECTRON MICROSCOPY STUDY1$ - 0151.25
88350IMMUNOFLUORESCENT STUDY, EA ADDITIONAL ANTIBODY11$ - 013511.25
88360QUANT IMMUNOHISTOCHEMISTRY, EACH ANTIBODY13$ - 015012.50
88364TISSUE IN SITU HYBRIDIZATION, EA ADDTL PROBE1$ - 010.08
88365TISSUE IN SITU HYBRIDIZATION, 1ST PROBE1$ - 010.08
88377MORPHOMETRIC ANALYSIS, IN SITU, MANL,EA MULTIPLEX1$ - 010.08
88381MICRODISSECTION10$ - 012010.00
FY19 Base Period Total$ - 0

FY20 - Option 1

Immunochemistry Stains FY20
1 Oct 2019 to 30 Sep 2020
CPTDescriptionEstimated Quantity
Unit Price per ResultExtended Price
81210MOLECULAR BRAF, GENE ANALYSIS20$ - 0
81235MOLEC EGFR GENE ANALYSIS, COMMON VARIANTS20$ - 0
81275KRAS GENE ANALYSIS15$ - 0
81276KRAS EXON 3 VARIANTS15$ - 0
81301MICROSATELLITE INSTABILITY ANALYSIS20$ - 0
81305MYD88 GENE ANALYSIS5$ - 0
81311NRAS EXON 2, 3 VARIANTS5$ - 0
81403JAK2; LEVEL 4 DNA SEQUENCE ANALYSIS5$ - 0
81404PIK3CA5$ - 0
88237TISS CULT FOR NEOPLST DISORDERS, BN MRW, BLD CELL10$ - 0
88239TISSUE CULTURE FOR CHROMOSOME-SOLID TUMOR10$ - 0
88261CHRM ANALYSIS,CT 5 CELL, 1 KAROTYPE WITH BANDING10$ - 0
88262CHROMOSOME ANALYSIS, 15-20 CELLS10$ - 0
88263CHROMOSOME ANALYSIS, COUNT 45 CELLS FOR MOSAICISM5$ - 0
88264CHROMOSOME ANALYSIS, 20-25 CELLS10$ - 0
88267CHRM ANALYSIS,AMNIO FLD OR CHORIONIC VILLUS CNT 15 CL10$ - 0
88271MOLECULAR CYTOGENETICS PROBE20$ - 0
88280CHRM ANALYSIS; ADDITIONAL KAROTYPES, EACH STUDY20$ - 0
88291INTERPRETATION AND REPORT200$ - 0
88305GROSS & MICRO, LEVEL 415$ - 0
88313SPECIAL STAIN, ROUTINE45$ - 0
88321PATHOLOGY SLIDE CONSULT30$ - 0
88323PATHOLOGY CONSULTATION WITH PROCESSING45$ - 0
88341IMMUNOHISTOCHEMISTRY,EACH ADDITIONAL ANTIBODY275$ - 0
88341TCTECH ‐ IMMUNOHISTOCHEMISTRY,EACH ADDTL ANITBODY1$ - 0
88342IMMUNOHISTOCHEMISTRY, 1ST ANTIBODY100$ - 0
88342TCTECH ‐ IMMUNOHISTOCHEMISTRY, 1ST ANTIBODY1$ - 0
88346IMMUNOFLUORESCENT STUDY, EA SPECIMEN 1ST ANTIBODY15$ - 0
88348ELECTRON MICROSCOPY STUDY15$ - 0
88350IMMUNOFLUORESCENT STUDY, EA ADDITIONAL ANTIBODY135$ - 0
88360QUANT IMMUNOHISTOCHEMISTRY, EACH ANTIBODY150$ - 0
88364TISSUE IN SITU HYBRIDIZATION, EA ADDTL PROBE1$ - 0
88365TISSUE IN SITU HYBRIDIZATION, 1ST PROBE1$ - 0
88377MORPHOMETRIC ANALYSIS, IN SITU, MANL,EA MULTIPLEX1$ - 0
88381MICRODISSECTION120$ - 0
FY20 OY1 Period Total$ - 0

FY21 - Option 2

Immunochemistry Stains FY21
1 Oct 2020 to 30 Sep 2021
CPTDescriptionEstimated Quantity
Unit Price per ResultExtended Price
81210MOLECULAR BRAF, GENE ANALYSIS20$ - 0
81235MOLEC EGFR GENE ANALYSIS, COMMON VARIANTS20$ - 0
81275KRAS GENE ANALYSIS15$ - 0
81276KRAS EXON 3 VARIANTS15$ - 0
81301MICROSATELLITE INSTABILITY ANALYSIS20$ - 0
81305MYD88 GENE ANALYSIS5$ - 0
81311NRAS EXON 2, 3 VARIANTS5$ - 0
81403JAK2; LEVEL 4 DNA SEQUENCE ANALYSIS5$ - 0
81404PIK3CA5$ - 0
88237TISS CULT FOR NEOPLST DISORDERS, BN MRW, BLD CELL10$ - 0
88239TISSUE CULTURE FOR CHROMOSOME-SOLID TUMOR10$ - 0
88261CHRM ANALYSIS,CT 5 CELL, 1 KAROTYPE WITH BANDING10$ - 0
88262CHROMOSOME ANALYSIS, 15-20 CELLS10$ - 0
88263CHROMOSOME ANALYSIS, COUNT 45 CELLS FOR MOSAICISM5$ - 0
88264CHROMOSOME ANALYSIS, 20-25 CELLS10$ - 0
88267CHRM ANALYSIS,AMNIO FLD OR CHORIONIC VILLUS CNT 15 CL10$ - 0
88271MOLECULAR CYTOGENETICS PROBE20$ - 0
88280CHRM ANALYSIS; ADDITIONAL KAROTYPES, EACH STUDY20$ - 0
88291INTERPRETATION AND REPORT200$ - 0
88305GROSS & MICRO, LEVEL 415$ - 0
88313SPECIAL STAIN, ROUTINE45$ - 0
88321PATHOLOGY SLIDE CONSULT30$ - 0
88323PATHOLOGY CONSULTATION WITH PROCESSING45$ - 0
88341IMMUNOHISTOCHEMISTRY,EACH ADDITIONAL ANTIBODY275$ - 0
88341TCTECH ‐ IMMUNOHISTOCHEMISTRY,EACH ADDTL ANITBODY1$ - 0
88342IMMUNOHISTOCHEMISTRY, 1ST ANTIBODY100$ - 0
88342TCTECH ‐ IMMUNOHISTOCHEMISTRY, 1ST ANTIBODY1$ - 0
88346IMMUNOFLUORESCENT STUDY, EA SPECIMEN 1ST ANTIBODY15$ - 0
88348ELECTRON MICROSCOPY STUDY15$ - 0
88350IMMUNOFLUORESCENT STUDY, EA ADDITIONAL ANTIBODY135$ - 0
88360QUANT IMMUNOHISTOCHEMISTRY, EACH ANTIBODY150$ - 0
88364TISSUE IN SITU HYBRIDIZATION, EA ADDTL PROBE1$ - 0
88365TISSUE IN SITU HYBRIDIZATION, 1ST PROBE1$ - 0
88377MORPHOMETRIC ANALYSIS, IN SITU, MANL,EA MULTIPLEX1$ - 0
88381MICRODISSECTION120$ - 0
FY21 OY1 Period Total$ - 0

File details come from the government source that posted it.